VAS
GMAB icon

Vestmark Advisory Solutions’s Genmab GMAB Stock Holding History

Vestmark Advisory Solutions’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Sell
55,781
-3,525
-6% -$93.7K 0.01% 822
2026
Q1 		$1.59M Sell
59,306
-50,052
-46% -$1.5M 0.02% 718
2025
Q4 		$3.37M Buy
+109,358
New +$3.41M 0.05% 411
2025
Q1 		– Sell
-20,184
Closed -$421K – 645
2024
Q4 		$421K Sell
20,184
-7,795
-28% -$171K 0.01% 440
2024
Q3 		$682K Buy
27,979
+335
+1% +$8.96K 0.03% 347
2024
Q2 		$695K Sell
27,644
-466
-2% -$13.2K 0.03% 358
2024
Q1 		$841K Sell
28,110
-7,546
-21% -$222K 0.04% 327
2023
Q4 		$1.14M Buy
35,656
+7,905
+28% +$248K 0.06% 277
2023
Q3 		$979K Sell
27,751
-10,584
-28% -$403K 0.07% 246
2023
Q2 		$1.46M Buy
38,335
+401
+1% +$16K 0.06% 365
2023
Q1 		$1.43M Sell
37,934
-7,065
-16% -$272K 0.06% 348
2022
Q4 		$1.91M Sell
44,999
-9,020
-17% -$372K 0.09% 288
2022
Q3 		$1.74M Buy
54,019
+14,878
+38% +$522K 0.1% 284
2022
Q2 		$1.27M Buy
39,141
+17,394
+80% +$564K 0.07% 309
2022
Q1 		$787K Sell
21,747
-7,446
-26% -$256K 0.04% 422
2021
Q4 		$1.16M Sell
29,193
-1,584
-5% -$66.1K 0.07% 335
2021
Q3 		$1.34M Buy
30,777
+10,046
+48% +$451K 0.09% 282
2021
Q2 		$846K Buy
20,731
+6,421
+45% +$248K 0.06% 357
2021
Q1 		$470K Sell
14,310
-4,665
-25% -$175K 0.04% 454
2020
Q4 		$772K Buy
18,975
+1,326
+8% +$49.6K 0.09% 280
2020
Q3 		$646K Buy
17,649
+2,300
+15% +$83.2K 0.09% 284
2020
Q2 		$520K Sell
15,349
-12
-0.1% -$327 0.08% 297
2020
Q1 		$325K Buy
15,361
+1,412
+10% +$31.5K 0.06% 342
2019
Q4 		$311K Buy
13,949
+698
+5% +$15.2K 0.06% 227
2019
Q3 		$268K Buy
+13,251
New +$261K 0.04% 451

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vestmark Advisory Solutions's GMAB Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Genmab (GMAB) stake by 5.9% in Q2 2026, selling an estimated $93.7K and leaving 55,781 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #822.

Vestmark Advisory Solutions first reported a position in GMAB in Q3 2019 and has held it in 25 quarters since. The position peaked at $3.37M in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Vestmark Advisory Solutions held 55,781 shares of Genmab worth $1.53M as of Q2 2026.
  • Vestmark Advisory Solutions sold 3,525 Genmab shares in Q2 2026, an estimated $93.7K.
  • Genmab made up 0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #822 holding.
  • Vestmark Advisory Solutions first reported a position in Genmab in Q3 2019 and has held it in 25 quarters since.
  • Vestmark Advisory Solutions's Genmab position peaked at $3.37M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.